Canadian company Dalsa has released a proprietary digital x-ray camera designed to replace conventional x-ray film cassettes for mammography. Savvas Chamberlain, Dalsa's CEO, said his company has a two-year lead on the competition in this field
Canadian company Dalsa has released a proprietary digital x-ray camera designed to replace conventional x-ray film cassettes for mammography. Savvas Chamberlain, Dalsa's CEO, said his company has a two-year lead on the competition in this field because its new imaging system uses digital images captured by an x-ray camera to calculate the correct three-dimensional positioning of a biopsy needle.
During a diagnostic mammogram using Dalsa's new system, patients will no longer be required to remain clamped in the x-ray system while films are developed and analyzed because the camera provides real-time images and onscreen diagnostic tools, the company said.
These tools help the physician to accurately place the biopsy needle the first time. The new imaging system is designed to either replace x-ray film cassettes in existing systems or be incorporated into new digital equipment. Dalsa plans to market the camera in its fourth quarter, if it gains FDA approval.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.